Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Compagnie réclamée
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions Lire la suite
There are some great people working there, but it is ruined by how the company is run by upper management. People don't feel respected or feel that their contributions are appreciated.
Quelle est la meilleure partie de votre programme de rémunération?
The employee stock purchase plan
Qu’est-ce qui ne va pas et comment cela peut-il être amélioré?
The daily stress and work hours need to be reduced.
De quoi l’équipe de direction a-t-elle besoin pour s’améliorer?
They need to respect their employees as people and respect their lives and responsibilities outside of work.
Qu’est-ce que vos collègues doivent améliorer et comment pouvez-vous mieux travailler ensemble?
People do not have time to do a task so there is always conflicts around priorities and people not meeting timelines
Que faut-il changer pour améliorer la culture de l’entreprise?
The expectation of being available 24/7 including holidays leads to quick burnout. There is no respect for the employees and what is being asked of them. Upper management needs to provide more resources and stop pushing the employees to the point of exhaustion and burnout.
Other Employee Reviews for Karyopharm Therapeutics
×